From today's NYT:
"Although tests of TGN1412 in monkeys showed no significant trouble, all six human subjects nearly died."
"...the British government announced it was convening an international panel of experts to "consider what necessary changes to clinical trials may be required."
"In statements this week, both Parexel and the drug's manufacturer, TeGenero, emphasized that they had complied with all regulatory requirements and conducted the trial according to the approved protocol. But they declined to answer questions e-mailed to them about the specifics of the science involved. "